NCT00913822View on ClinicalTrials.gov

To Demonstrate the Relative Bioavailability of Desipramine Hydrochloride Tablets

PHASE1CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

December 31, 1987

Primary Completion Date

December 31, 1987

Study Completion Date

December 31, 1987

Conditions
Depression
Interventions
DRUG

Desipramine Hydrochloride 100 mg Tablets (Cord Laboratories)

DRUG

Norpramin 100 mg Tablets (Merrell Dow Pharmaceuticals, Inc.)

Sponsors

Lead Sponsor

Sandoz
All Listed Sponsors
lead

Sandoz

INDUSTRY

NCT00913822 - To Demonstrate the Relative Bioavailability of Desipramine Hydrochloride Tablets | Biotech Hunter | Biotech Hunter